Business Context and Reporting Period
This Form 8-K Current Report was filed by Wave Life Sciences Ltd. on August 22, 2016, covering events occurring on August 16, 2016. The filing primarily addresses the appointment of a new Chief Financial Officer and the terms of his employment agreement.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to executive compensation:
- Base Salary: $320,000 annually.
- Annual Performance Bonus: Up to 40% of base salary.
- Equity Grant: 120,000 share options at an exercise price of $20.89 per share.
Material Changes
The material change reported is the appointment of Keith Regnante as Chief Financial Officer, effective August 16, 2016. He assumes the roles of principal financial officer and principal accounting officer. Kyle Moran, who previously served in these roles on an interim basis, will transition to Vice President, Head of Finance.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, financial outlook, or management commentary regarding the company's business strategy or market conditions. It details the terms of Mr. Regnante's employment agreement, including:
- Vesting Schedule: Options vest over four years (25% on the first anniversary, then monthly).
- Change of Control: Unvested options become fully vested and exercisable upon a change of control.
- Severance: Involuntary termination without cause triggers 12 months of base salary continuation and health insurance. Termination following a change of control includes a lump sum of 12 months' salary, a prorated bonus, and health insurance continuation.
Investor Verification Checklist
- Verify the full text of the executive employment agreement when filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2016.
- Confirm the impact of the new CFO appointment on the company's financial reporting and strategic direction.
- Review the press release issued on August 17, 2016 (Exhibit 99.1) for additional context on the leadership transition.